Source link : https://www.newshealth.biz/health-news/academics-pharma-big-bucks-new-car-t-warnings-patients-seek-cancer-tests/
Amid controversy and discussions about the high cost of cancer drugs, some academic medical centers profit handsomely from pharma-paid royalties on drugs developed with public funding. (Los Angeles Magazine) The FDA has mandated updates to boxed warnings and labeling for CAR T-cell therapies related to a serious risk of T-cell malignancies associated with all BCMA- […]
Author : News Health
Publish date : 2024-04-19 19:18:14
Copyright for syndicated content belongs to the linked Source.